Real Life Pharmacology - Pharmacology Education for Health Care Professionals podcast

Teplizumab For Diabetes Episode 315 – Real Life Pharmacology Podcast

0:00
15:37
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder
Teplizumab is a relatively new agent that helps delay the progression of type 1 diabetes. It slows the rate of beta-cell destruction in the pancreas. Teplizumab is associated with cytokine release syndrome which can result in flu-like symptoms of fever, aches, and headache. Cytokine release syndrome due to teplizumab can be reduced by using appropriate pretreatment medications. Those medications can include analgesics, antihistamines, and/or antiemetics. Teplizumab is associated with suppressing the immune system so it is ideal to get vaccinations completed before using this medication. I go over the specific recommendations in the podcast episode.

Fler avsnitt från "Real Life Pharmacology - Pharmacology Education for Health Care Professionals"